{"name":"Lihir Medical Centre","slug":"lihir-medical-centre","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"R3-Total community treatment with azithromycin","genericName":"R3-Total community treatment with azithromycin","slug":"r3-total-community-treatment-with-azithromycin","indication":"Other","status":"marketed"},{"name":"R3-Total targeted treatment with azithromycin","genericName":"R3-Total targeted treatment with azithromycin","slug":"r3-total-targeted-treatment-with-azithromycin","indication":"Other","status":"marketed"},{"name":"Ivermectin on Day 1","genericName":"Ivermectin on Day 1","slug":"ivermectin-on-day-1","indication":"Onchocerciasis (river blindness)","status":"phase_3"},{"name":"R2-Total targeted treatment with azithromycin","genericName":"R2-Total targeted treatment with azithromycin","slug":"r2-total-targeted-treatment-with-azithromycin","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"cardiovascular","drugs":[{"name":"Azithromycin on Day 1","genericName":"Azithromycin on Day 1","slug":"azithromycin-on-day-1","indication":"Bacterial respiratory tract infections (community-acquired pneumonia, bronchitis)","status":"phase_3"},{"name":"Azithromycin on Day 8","genericName":"Azithromycin on Day 8","slug":"azithromycin-on-day-8","indication":"Community-acquired pneumonia","status":"phase_3"},{"name":"Diethylcarbamazine on day 1","genericName":"Diethylcarbamazine on day 1","slug":"diethylcarbamazine-on-day-1","indication":"Lymphatic filariasis (Wuchereria bancrofti, Brugia malayi infection)","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Albendazole on Day 1","genericName":"Albendazole on Day 1","slug":"albendazole-on-day-1","indication":"Soil-transmitted helminth infections (Ascaris lumbricoides, Trichuris trichiura, Necator americanus, Ancylostoma duodenale)","status":"phase_3"}]}],"pipeline":[{"name":"R3-Total community treatment with azithromycin","genericName":"R3-Total community treatment with azithromycin","slug":"r3-total-community-treatment-with-azithromycin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"R3-Total targeted treatment with azithromycin","genericName":"R3-Total targeted treatment with azithromycin","slug":"r3-total-targeted-treatment-with-azithromycin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Albendazole on Day 1","genericName":"Albendazole on Day 1","slug":"albendazole-on-day-1","phase":"phase_3","mechanism":"Albendazole inhibits microtubule polymerization in parasitic worms by binding to β-tubulin, disrupting their cytoskeletal structure and causing paralysis and death.","indications":["Soil-transmitted helminth infections (Ascaris lumbricoides, Trichuris trichiura, Necator americanus, Ancylostoma duodenale)","Cysticercosis (neurocysticercosis)","Echinococcosis (hydatid disease)","Strongyloidiasis"],"catalyst":""},{"name":"Azithromycin on Day 1","genericName":"Azithromycin on Day 1","slug":"azithromycin-on-day-1","phase":"phase_3","mechanism":"Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and halting bacterial growth.","indications":["Bacterial respiratory tract infections (community-acquired pneumonia, bronchitis)","Sexually transmitted infections (chlamydia, gonorrhea)","Skin and soft tissue infections","Otitis media"],"catalyst":""},{"name":"Azithromycin on Day 8","genericName":"Azithromycin on Day 8","slug":"azithromycin-on-day-8","phase":"phase_3","mechanism":"Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby stopping bacterial growth.","indications":["Community-acquired pneumonia","Acute bacterial sinusitis","Acute otitis media","Pharyngitis/tonsillitis","Bronchitis"],"catalyst":""},{"name":"Diethylcarbamazine on day 1","genericName":"Diethylcarbamazine on day 1","slug":"diethylcarbamazine-on-day-1","phase":"phase_3","mechanism":"Diethylcarbamazine immobilizes and kills microfilariae by interfering with their neuromuscular function, making them susceptible to immune clearance.","indications":["Lymphatic filariasis (Wuchereria bancrofti, Brugia malayi infection)","Loiasis (Loa loa infection)","Onchocerciasis (as adjunctive therapy)"],"catalyst":""},{"name":"Ivermectin on Day 1","genericName":"Ivermectin on Day 1","slug":"ivermectin-on-day-1","phase":"phase_3","mechanism":"Ivermectin is a macrocyclic lactone that binds to glutamate-gated chloride channels in parasites, causing paralysis and death.","indications":["Onchocerciasis (river blindness)","Lymphatic filariasis","Strongyloidiasis","Scabies","Lice infestation"],"catalyst":""},{"name":"R2-Total targeted treatment with azithromycin","genericName":"R2-Total targeted treatment with azithromycin","slug":"r2-total-targeted-treatment-with-azithromycin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE1kV3RBSGNlZTl2TUxIZS1FUm1aVVhFX2JkT29Ma3FwVmRpOGtxclZoZVU1TWo4V3hzb05ZaGYySzVkNTNRZWtRX3BWQVBCcEgzYXhjNWxSczdYblpIeHNUV3VuNVVpMDl0UnlBeFlPazFaNzVIcmxENmlR?oc=5","date":"2021-04-16","type":"pipeline","source":"The National | Your Number One Daily!","summary":"Medical supplies worth K542,000 donated - The National | Your Number One Daily!","headline":"Medical supplies worth K542,000 donated - The National | Your Number One Daily!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQOGU2Rng4UFpxODZ0NGtRS05tX3dkbTNLeHpGVklveTI4elUxdWZubTEwa19QVkNid0NtZERMNlZiNUFVUGZ2ZWxMbWdCYVB2Qk15U2V1U1NGS3dkSzB6T0lTZnhHNzRtTmdjYVlkdWtHUjQ4ZDBYQndaeUtaN3B3Qjk5VdIBlwFBVV95cUxPYXJCZms3QXRIdGZvVE5GN1Q4R2xmY3prT0RuS1drSDBiTG1Xa2FPZFA3bFZ0a2pqcWt3cW9Ncmp2Y203Rmp5VzZpdllaMXhEb0JpQkh6dk95a1BjbGpUb0JELVFPdjhXdC1Wc2g5VTB3TEFVdUlSbG1vMHRoNzNVWm5ldG5qdHBsb0lOZnhZLUdSdGtWRFVZ?oc=5","date":"2015-02-20","type":"pipeline","source":"EL PAÍS English","summary":"The young Spanish doctor working to eradicate a tropical infection - EL PAÍS English","headline":"The young Spanish doctor working to eradicate a tropical infection - EL PAÍS English","sentiment":"neutral"}],"patents":[],"drugCount":8,"phaseCounts":{"marketed":3,"phase_3":5},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}